Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial

Surgical resection offers the best chance for cure for early stage non-small-cell lung cancer (NSCLC, stage I, II, IIIA), but the 5-year survival rates are only moderate, with systemic relapse being the major cause of death. Pre-operative (neo-adjuvant) chemotherapy has shown promise in small trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, R H de, Smith, I E, Pastorino, U, O'Brien, M E R, Ramage, F, Ashley, S, Goldstraw, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362739/
https://www.ncbi.nlm.nih.gov/pubmed/10188899
http://dx.doi.org/10.1038/sj.bjc.6690241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362739/
https://www.ncbi.nlm.nih.gov/pubmed/10188899
http://dx.doi.org/10.1038/sj.bjc.6690241

Ejemplares similares